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Abstract
Regenerative repair of large bone defects currently remains a challenging issue during
surgery, owing to the limited regenerative ability of the bone. To address this issue, we
attempted a precise repair of a bone defect using computer-aided procedures. Using
pelvic computed tomography (CT) images of beagle dogs, virtual tumors were created
in the pelvis using computer-aided design (CAD), and a bone resection following the
margins of the bone tumor was performed on the CAD image. Hydroxyapatite (HA)
implants to fill the bone defects and implants for shape evaluation of bone resection
sites  were  designed  and  produced  by  computer-aided  manufacturing  and  three-
dimensional printing. Subsequently, using a computer navigation system, iliac bone
defects were created in beagle dogs as preoperatively planned on CAD, filled with HA
implants shaped to fit the bone defect sites, and coated with a recombinant human bone
morphogenetic protein (rhBMP)-2-containing dough bone-forming material. Postoper‐
ative  CT revealed  that  the  new bone  was  formed around the  implant  over  time.
Anatomical healthy bone repair was confirmed to be completed 12 weeks after the
surgery.  These  results  demonstrate  potential  novel  technology  for  efficacious  and
accurate repair of large bone defects without bone grafting.
Keywords: regenerative repair, bone defect, computer-aided design, computer-assist‐
ed surgery, 3D printing
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1. Introduction
Extensive bone defects can occur after severe trauma, infection, or bone tumor resection, and in
some cases require bone tissue reconstruction. Therefore, auto/allografts and artificial materi‐
als are implanted. Materials currently used for bone tissue reconstruction include autologous
bone tissue, such as the ilium and fibula, and allogeneic materials, such as cryopreserved bone,
titanium alloys, and bioactive ceramics [1]. Each of these has distinct advantages, but they also
have various disadvantages or problems that remain to be solved.
The autologous bone is the most effective material for small bone defects and is characterized
by strong bone-forming ability, accompanied by the capability of bone union and remodeling
capacity. However, it has disadvantages, including limitations in the collectable quantity and
complications after collection, such as pain, infection, fracture, deformation, and risk of
damage to major nerves or blood vessels. The use of allogeneic bone is associated with low
bone-forming ability; potential transmission of infectious agents; and cost problems, including
cleanliness management. Disadvantages of the heterologous bone include possible transmis‐
sion of animal infections and immunological rejection in addition to those listed for allogeneic
bone [2–4].
Although artificial materials offer the advantages of easy access and processing, they are
usually incapable of practical bone formation and thus are ineffective for bone regeneration
in large bone defects. It is difficult to reconstruct relatively large bone defects in a shape that
is anatomically similar to the normal structure.
Scaffolds, growth factors, and cells represent three key elements in regenerative medicine. An
ideal approach for bone repair with regenerative medicine technology should have the abilities
of osteogenesis, osteoconduction, osteoinduction, and osteointegration to resolve the disad‐
vantages of currently available graft materials. Biocompatible and biodegradable scaffolds
include those made of biological materials, such as type 1 collagen and demineralized bone,
and of synthetic (artificial) materials, such as porous metals, bioactive glass, synthetic poly‐
mers, and calcium phosphate ceramics [hydroxyapatite (HA) and tricalcium phosphate (TCP)]
[5].
Among bone morphogenetic proteins (BMP), recombinant human BMP (rhBMP)-2 and -7 are
potent osteoinductive cytokines and are clinically used as graft materials in spinal fusion,
pseudarthrosis after long bone fractures, repeated posterolateral fusion, and treatment of open
fractures of the tibia in some countries, such as European countries and the United States. We
expect that they will find increasing application in bone-regenerating medicine because of their
high rates of bone union and their simplicity and minimal invasiveness (i.e., bone harvesting
is not required) [6–8].
Recent advances in computer-assisted techniques have led to computer-assisted preoperative
planning, custom production of surgical implants using patient data, and use of navigation
systems in orthopedics. Examples include three-dimensional (3D) printing-based preoperative
planning, in which 3D printing of the relevant bone is performed before a trauma patient
undergoes surgery and plates to be used are templated with the reference to the simulated
New Trends in 3D Printing144
bone so that no intraoperative plate bending maneuvers are required. Furthermore, the pre-
bent plate itself serves as a reduction indicator, and accurate corrective osteotomy procedures
for malunited fractures are prepared for each patient using osteotomy guides [9, 10]. In
addition, the use of navigation systems has been reported to be useful in joint surgery, for
example, for accurate installation of artificial joint components, safe and accurate insertion of
pedicle screws in spinal fusion, and resection of musculoskeletal tumors [11–13].
These computer-assisted imaging technologies might be applicable for repair of large bone
defects that result from wide resection of malignant musculoskeletal tumors. In those cases,
the decision regarding optimal resection margins should be based on 3D computed tomogra‐
phy (CT) or/and magnetic resonance imaging (MRI) data to avoid exposure of the tumor tissue
to the surgical field and late local recurrence of the tumor, and the image data would be
applicable to surgical procedures using computer-assisted navigation surgery (CAS) system.
Image data of the virtual bone defect in the computer-aided design (CAD) would be used to
fabricate a porous HA block implant with computer-assisted manufacturing system (CAM) to
fill the bone defect. To add osteoinductive capacity to the HA implant to accelerate bone defect
repair, a cytokine rhBMP-2 with potent osteoinductive capacity retained in its dough-like
delivery system is pasted on the HA surface during implantation.
In this study, we investigated the feasibility of computer-assisted technology (CAD, CAM, and
CAS) for preoperative surgical planning and corrective surgical procedures to resect a virtual
tumor and fabricate an HA implant. Another aim was to estimate the efficacy of rhBMP-2 and
its delivery system to promote repair of a large bone defect without bone grafting in a beagle
model.
2. Experiments
2.1. Methods
2.1.1. Preoperative planning
In beagle dogs (male, 10-month-old, body weight: 9–11 kg) scheduled for surgery, pelvic CTs
were performed a few days before the surgery, and the acquired data [digital imaging and
communication in medicine (DICOM)] were used for preoperative planning with CAD
software (Mimics, Magics, Materialise, NV, USA). 3D images created from CT data after
DICOM data are transferred to CAD and converted into a standard triangulated language
format that can be separated or combined in any way with CAD. On the 3D images of the
pelvis obtained in this manner, a virtual bone tumor of 15 mm in diameter was created in the
left iliac wing, and a bone resection model was created by establishing the bone resection line,
10 mm distant from the tumor (Figure 1a and b). An implant was designed to compensate for
the defect occurring after resection by subtracting the bone defect part from a mirror image of
the right ilium (Figure 2a).
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Figure 1. (a) A virtual spherical bone tumor of 15 mm in diameter (color: orange) was created in the left iliac wing of
the canine pelvis with preoperative planning on computer-aided design (CAD) software. The bone resection line was
set 10 mm distant from the bone tumor on the CAD image (color: green). (b) A bone resection model was established
on CAD image.
Figure 2. (a) CAD image of defected bone generated by subtracting the left iliac bone from the mirror image of the
right iliac bone. (b) Fabricated interconnected porous calcium hydroxyapatite (IP-CHA) block by using a 3D drilling
machine based on CAD data. Multiple dimples were made to facilitate retention of the BMP-retaining dough material.
(c) BMP-retaining biodegradable dough material.
2.1.2. Implant preparation
We selected an artificial bone made of interconnected porous calcium HA (IP-CHA, pore size:
150 μm, porosity: 72–78%, MMT Co., Ltd., Osaka, Japan) as a material to fill the defect because
of its high osteoconductive capacity [14]. CT data of the bone defect as described above were
transferred to a 3D cutting machine (CAM; Modela player, Roland DG Co., Shizuoka, Japan),
and an IP-CHA block (cuboid, 40 × 20 × 10 mm) was processed with a 3D drilling machine
(MDZ-20, Roland DG Co.). The processed HA block was then machined with a high-speed
surgical drill to create a large number of dimples facilitating the application of a BMP-
containing dough bone-forming material (described below) (Figure 2b). To confirm the size
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of the defect at the bone resection site during surgery, CAD design data were migrated to a
3D printer (ZPrinter Z-310, Toyotsu machinery, Aichi, Japan) and printed with gypsum. These
were autoclaved or gas sterilized so that they could be used during surgery.
2.1.3. Dough bone-forming material
Because BMP administered alone rapidly diffuses in vivo, it cannot maintain the local
concentration at a level required for bone formation and thus does not induce bone formation.
Therefore, an appropriate slow-release carrier (drug delivery system, DDS) is necessary to
accomplish effective bone formation with BMP. Bovine type 1 collagen is currently used as a
DDS for BMP, but it has the disadvantages of requiring a large amount of expensive BMP and
the potential transmission of pathogens, such as variant Creutzfeldt-Jakob disease, which
cannot be completely excluded [4].
To solve these problems, our group has developed a poly-d, l-lactic acid-polyethylene glycol
block copolymer (PLA-PEG, Taki Chemical Co., Ltd., Kakogawa, Japan), which is a fully
synthetic artificial DDS material that reduces the BMP dose required for bone formation [15–
25]. Given that the PLA-PEG polymer is viscous at room temperature, it is difficult to process
manually but can be transformed into a dough-like material by the addition of powdery β-
TCP, which can be readily processed. By adding BMP to this mixture, we devised a dough-
like bone-forming material (Figure 2c) [26–32]. rhBMP-2 was synthesized by Escherichia coli
transfected with the rhBMP-2 gene. After inactive monomer rhBMP-2 molecules were
produced, they were dimerized to active rhBMP-2 by biochemical processing. The BMP-2
delivery system for one IP-CHA implant was generated by mixing 100 μg of rhBMP-2
(Osteopharma Inc., Osaka, Japan), 200 mg of powdery β-TCP (particle size <100 μm in
diameter, Olympus Biomaterial Corp., Tokyo, Japan), and 200 mg of the PLA-PEG polymer
[33]. Physiochemical characteristics of this dough bone-forming material have been reported
previously. Dough bone-forming material preparations devoid of rhBMP-2 were prepared as
the control group. The samples were stored at −30°C until use during surgery.
2.2. Bone resection with the navigation system and implantation of BMP-added IP-CHA
implant
Data of the bone resection model created with CAD software were converted into the DICOM
format. Converted DICOM data were transferred to a CT-based computer navigation system
(Stealth Station Tria, Medtronic Navigation, Louisville, Co, USA). Anesthesia, ketamine (10
mg/kg) and xylazine (1.2 mg/kg) was injected intramuscularly and maintained with a contin‐
uous pentobarbital (25 mg/kg) intravenously. The left ilium was opened at the acetabular
margin in beagle dogs in the right lateral decubitus position. A reference frame was secured
to the iliac wing with two threaded pins and matched with navigation by point and surface
registration. A Surgairtome equipped with a passive pointer was used for bone resection. Bone
resection was performed as preoperatively planned according to the navigation system. The
accuracy of bone resection was evaluated by testing the fit of the 3D printer-produced gypsum
implant. The dough bone-forming material was then pasted evenly on the surface of the
preoperatively designed and processed HA implant, and the coated implant was secured with
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two or three 0.6 mm wires (Synthes Co., Ltd., Tokyo, Japan). The implant was carefully sutured
in place to ensure contact with the surrounding muscle. A prophylactic antibiotic agent (10
mg/kg body weight) was administered to animals before and after the surgery. This animal
experiment was performed after institutional approval was obtained.
2.3. Evaluation of efficacy of computer-assisted bone defect repairing system
CT slice images of the iliac bone were obtained immediately and 3, 6, 9, and 12 weeks post‐
operatively to observe the bone repair reaction at the bone defect site and reconstructed into
slice and 3D images as desired using the reconstruction software (Aze, Tokyo, Japan). CT
images of the mid-axial slice of the implant and the next slice 1 mm from the center were
analyzed. A high-density area surrounding the implant was considered to be a new bone area
and quantified with ImageJ software (Wayne Rasband, National Institutes of Health, Bethesda,
MD). Results were statistically analyzed by the Mann-Whitney U test with a significance level
of P < 0.05. The ilium was harvested 12 weeks postoperatively and fixed in 70% ethanol. From
un-decalcified specimens, 10 μm sections were prepared and subjected to Villanueva bone
staining for histological evaluation. Specimens were macroscopically evaluated.
3. Results
3.1. Accuracy of iliac bone resection by computer-aided surgery
In all animals, navigation-guided osteotomy could be accurately performed on the virtual bone
tumor exactly as planned on the CAD system. The CAD-designed, 3D printer-produced
Figure 3. Representative mid-axial plane images of computed tomography (CT) sequentially taken over the experi‐
mental period. (a) In the BMP-treated group, radiopaque images were observed on the IP-CHA surface 3 weeks post‐
operatively. The radiologically dense area around the implant increased in a time-dependent manner. The implant was
completely covered by new bone at 12 weeks postoperatively. (b) No significant radiopaque images were observed in
the control group up to 12 weeks postoperatively.
New Trends in 3D Printing148
implant fitted into the bone defect, and the IP-CHA implant prepared by CAD and CAM fitted
well in all experimental and control animals. Over the 12-week study period, all animals
survived without any complication.
3.2. Evaluation of bone defect repair using reconstructed CT images
Figure 3 shows representative mid-axial plane images sequentially taken over the experimen‐
tal period in the BMP-treated group and no-BMP control group. In the BMP-treated group, in
which the IP-CHA surface was coated with the BMP-retaining dough material, radiopaque
images were observed on the implant surface 3 weeks postoperatively. Thereafter, the
radiologically dense area around the implant increased in a time-dependent manner, and the
implant was completely covered by radiopaque images at 12 weeks postoperatively. In
contrast, no significant radiopaque images were observed in the control group images up to
12 weeks postoperatively.
3.3. Macroscopic and histological findings
Macroscopic findings for the BMP-treated group of animals indicated that the whole implant
was completely encased by a new bone, and the new bone was continuous with the original
ilium, suggesting successful repair of the bone defect to the normal anatomical morphology
Figure 4. (a) BMP-treated group. The whole implant was completely encased by a new bone continuous with original
ilium on macroscopic findings. (b) No bone tissue was observed on the implant surface in the control group.
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(Figure 4a). In contrast, no bone tissue was observed on the implant surface in the control
group of animals (Figure 4b). Representative histological specimens of un-decalcified tissues
with Villanueva bone staining are shown (Figure 5a–d). In the BMP-treated group, the implant
was covered by a new bone that was continuous with the original ilium, and the new bone
was found to have entered pores inside the implant (Figure 5c). The dough material pasted on
the implant surface was not observed in histological specimens obtained 12 weeks postoper‐
atively. This indicates biodegradation during the experimental period. No inflammatory
response was observed around the implant over the experimental period.
Figure 5. Histological sections at 12 weeks after surgery [lower (*20) and higher magnification (*200), scale bar indicates
100μm, 8μm in each magnification]. (a, b) Boxed area of reconstructed axial CT image shows a histological picture of
(c) (BMP-treated group) and (d) (control group), respectively. (c) In the BMP-treated group, the implant was covered
by a new bone that was continuous with the original ilium, and the new bone was observed in the pore of the implant.
d. In the control group, no bone tissue was observed. (arrowhead: new bone, asterisk: IP-CHA implant, cross: ilium,
arrow: fibrous tissue, circle: osteoid, box: calcified bone).
3.4. Changes over time in the amount of the new bone formed
In the BMP-treated group, the volume of the calcified new bone tissue around the implant on
CT slice images of the pelvis peaked 3 weeks postoperatively, then decreased over time, and
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finally resulted in the anatomical shape of the original ilium in 12 weeks postoperatively
(Figure 6). In contrast, significant new bone formation was not observed in the control group
during the observation period.
Figure 6. The amount of new bone formation of the BMP-treated group was significantly larger than that of the control
group in reconstructed mid-axial CT planes at all experimental periods (statistical significant difference was set at
p<0.05, values showed mean ± standard deviation).
4. Discussion
BMPs are established osteoinductive proteins, and BMP-2 and BMP-7, in particular, are used
in combination with animal-derived collagen as a carrier for spinal fusion, pseudarthrosis
treatment, and open fractures of the tibia [6–8]. These cytokine therapies accomplish a high
rate of bone union and have reduced the frequency of bone grafting. However, the currently
available carrier material of BMP is collagen derived from animals, which carries a possibility
of infectious pathogens. We established a new DDS of BMP-2; efficacy of the rhBMP-2-
retaining putty for repair of the large bone defect had been presented previously by our group
in other bone defect models in beagles and posterolateral spinal fusion models in rabbits. In
those experimental studies, a special A-B-A type of block copolymer (molecular weight 9,800,
A;-dl polyethylene glycol and B; polylactic acid) was successfully used as the carrier material for
BMP-2. The polymer was originally produced by us in collaboration with a chemical company
as an optimal delivery system for rhBMP-2. Because this polymer itself was highly sticky and
difficult to handle, an equal weight of biodegradable β-TCP powder was mixed with the
polymer to transform it to a slightly sticky putty or dough for easy implantation. Thus far,
with respect to the use of this carrier material in experimental animals, no local or systemic
adverse events were noted, and no significant inflammatory reaction has been observed on
histology. This synthetic carrier material is a candidate for efficacious use of rhBMP-2 to repair
or reconstruct the damaged bone after extensive safety check and clinical trials. Regarding the
Regenerative Repair of Bone Defects with Osteoinductive Hydroxyapatite Fabricated to Match the Defect and
Implanted with CAD, CAM, and Computer-Assisted Surgery Systems
http://dx.doi.org/10.5772/63743
151
rhBMP-2 dose added to the implant, 100 μg of rhBMP-2 in combination with 400 mg of the
delivery system (carrier material) per animal was used in the current study. This formulation
was fixed based on our previous experimental results obtained in beagle models. As widely
known, a minimal dose of BMP-2 to elicit local new bone formation in in vivo condition depends
on the animal species, and humans are less sensitive to BMP-2. Therefore, a higher BMP-2 dose
to the order of a few mg will be required for bone defect repair as observed in clinical reports
of rhBMP-2 used for spinal body fusion, non-union of fracture, and other off-label use of
rhBMP-2 in humans.
Recent reports have described successful reconstruction of maxillary bone defects in rabbits
and bone union achievement in rats with pseudarthrosis using a combination of BMP gene-
transfected cells and an artificial material or using sheets of cultured mesenchymal stem cells
[34, 35]. However, an expensive facility equipped with a special culture system is required to
establish a cell culture system for clinical application in humans. Conversely, BMPs can be
conveniently used anywhere, provided that the user has adequate storage expertise. In this
study, we accomplished the accurate skeletal reconstruction after resection in a virtual iliac
bone tumor model in beagle dogs by combining BMP with a 3D printer, CAD, CAM, and a
computer navigation system. In future, skeletal reconstruction will become possible for more
specialized skeletal tissue, such as the vertebral body and load-bearing sites.
In wide resection surgery of malignant musculoskeletal tumors, optimal tumor margins and
resection margin of the bone and soft tissue would be decided preoperatively on the basis of
CT and/or MRI to avoid exposing the tumor tissue to the surgical field and later local recurrence
of the tumor. But the accurate resection as planned preoperatively has often proven difficult.
In this experimental study, a CAS system of CT-based navigation was used as a guide for bone
resection margin, and the results indicated that it is possible to perform bone resection exactly
as planned using the CAS system. But planning of the exact resection margin of the soft tissue
covering the tumor was not attempted in this series, and similar studies based on CT and/or
MRI will be necessary to determine optimal resection margin of the soft tissue.
The 3D configuration of the defect on the left iliac bone after resection of the virtual tumor was
depicted on screen by subtraction of the 3D image of the left iliac bone from the 3D mirror
image of the right iliac bone. CT data of the defect images were then transferred to the CAM
system to drive the system to fabricate an IP-CHA implant to fill and fit the bone defect
generated in the left iliac bone. The shape and size of the implants thus fabricated were
acceptable and matched the defects well. However, the IP-CHA implant alone did not repair
the bone defect with a new bone, as observed in control animals, in spite of its high osteoin‐
ductive capacity due to its fully interconnected porous structure. To overcome this disadvant‐
age of the IP-CHA implant and to enhance regenerative potential of the implant, rhBMP-2 with
its potent bone-inducing capacity in combination with a specific delivery system (carrier
material for BMP-2) was added to the surface of the IP-CHA implant. This successfully elicited
new bone formation on the surface of the implant and restored normal anatomical surface
contour of the iliac bone in 12 weeks using the IP-CHA non-degradable block within the new
bone mass. Replacement of the non-biodegradable IP-CHA block by a porous β-TCP implant
might have resulted in complete regeneration of the bone defect without remnant biomaterials.
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However, because of the highly fragile nature of the porous TCP and easy breakage of the
implant during fabricating and surgical procedures, the IP-CHA implant was used in this
study, and the bone mass with stable connection to the original iliac bone and porous implant
was created.
Recent developments in 3D printing have expanded its range of application to include
production of implants, scaffolds for tissue engineering, and instruments for DDSs in addition
to visualization of surgical sites preoperatively and casting of surgical tools on the basis of the
additive manufacturing technology used in the present study. In addition, it has become
possible to directly print biological materials onto solvent-free, aqueous-based 3D scaffolds
for tissue transplantation [36–38]. Using CAD/CAM techniques, spatially defined implants can
be constructed by attaching functional living cells, physiological substances, and bioactive
factors in layers to organ scaffolds created on the basis of MRI or CT. For this bioprinting
technique, three major modes are currently available: inkjet, micro-extrusion, and laser-
assisted bioprinting. These modes differ in various properties, such as the range of material
viscosity accommodated, gelling method, viability, and concentration of cells to be handled.
Skin and cartilage regeneration by the inkjet method, creating heart valves and blood vessels
by the micro-extrusion method, and creating skin containing the heart tissue or cells by the
laser-assisted method have been reported [37, 38]. We expect that for cases involving extensive
tissue defects or requiring organ transplantation, printing technologies, scaffold development,
cell surgical techniques, and the use of growth factors will advance further and the scope of
clinical application will be further broadened if necessary tissues can be created in a shorter
period of time in the future.
5. Conclusion
Advances in computer-assisted techniques have led to computer-assisted preoperative
planning, custom production of surgical implants using patient data, and use of navigation
systems in orthopedics. In this study, we accomplished accurate skeletal reconstruction after
resection in a virtual iliac bone tumor model in beagle dogs by combining BMP with a 3D
printer, CAD, CAM, and a computer navigation system. In future, skeletal reconstruction will
become possible for more specialized skeletal tissues, such as the vertebral body and load-
bearing sites. Moreover, in future, the development of bioprinting techniques may enable us
to reconstruct extensive tissue defects or organ transplantation.
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